Provided by Tiger Fintech (Singapore) Pte. Ltd.

Senseonics

0.7020
-0.1680-19.31%
Post-market: 0.71950.0175+2.49%16:30 EST
Volume:15.79M
Turnover:10.97M
Market Cap:417.92M
PE:-5.39
High:0.7690
Open:0.6987
Low:0.6200
Close:0.8700
Loading ...

Company Profile

Company Name:
Senseonics
Exchange:
AMEX
Establishment Date:
1996
Employees:
132
Office Location:
20451 Seneca Meadows Parkway,Germantown,Maryland,United States
Zip Code:
20876-7005
Fax:
833 552 7007
Introduction:
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense, Eversense XL, and Eversense E3 which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Directors

Name
Position
Stephen P. DeFalco
Chairman
Timothy T. Goodnow
Director, President and Chief Executive Officer
Douglas A. Roeder
Director
Douglas S. Prince
Director
Edward J. Fiorentino
Director
M. James Barrett
Director
Peter Justin Klein
Director
Steven Edelman
Director

Shareholders

Name
Position
Timothy T. Goodnow
Director, President and Chief Executive Officer
Mukul Jain
Chief Operating Officer
R. Don Elsey
Chief Financial Officer, Secretary and Treasurer
Lynne E. Kelley
Chief Medical Officer
Mirasol Panlilio
Vice President, Global Sales and Marketing